financetom
Business
financetom
/
Business
/
Onestream Q3 Non-GAAP Operating Income Declines, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Onestream Q3 Non-GAAP Operating Income Declines, Revenue Rises
Nov 9, 2024 12:46 PM

06:04 PM EST, 11/07/2024 (MT Newswires) -- Onestream ( OS ) reported a Q3 non-GAAP operating income late Thursday of $5.5 million, compared with $8.4 million a year earlier.

Revenue in the quarter ended Sept. 30 was $129.1 million, up from $107 million a year earlier.

Analysts surveyed by Capital IQ expected $124.1 million.

In Q4, the company expects non-GAAP earnings per share of $0.01 to $0.03 on revenue of $127 million to $129 million. Analysts expect normalized EPS of $0.01 and $126.7 million in revenue.

For full-year 2024, Onestream ( OS ) now expects non-GAAP EPS of $0.06 to $0.08 on revenue of $484 million to $486 million. It previously projected a non-GAAP range of a loss of $0.05 a share to a profit of $0.01 on revenue of $476 million to $480 million. Analysts are looking for normalized loss per share of $0.02 and $478.6 million in revenue.

Price: 29.79, Change: -3.64, Percent Change: -10.89

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EU court upholds Google's $2.7 bln EU antitrust fine
EU court upholds Google's $2.7 bln EU antitrust fine
Sep 10, 2024
BRUSSELS, Sept 10 (Reuters) - Europe's top court on Tuesday upheld a 2.42 billion euro ($2.67 billion) EU antitrust fine imposed on Alphabet's Google seven years ago for using its own price comparison shopping service to gain an unfair advantage over smaller European rivals. The fine is one of three penalties levied by the European Commission against Google in the...
Jasper Therapeutics Says Health Canada Cleared Phase 1b/2a Briquilimab Asthma Study
Jasper Therapeutics Says Health Canada Cleared Phase 1b/2a Briquilimab Asthma Study
Sep 10, 2024
10:40 AM EDT, 09/10/2024 (MT Newswires) -- Jasper Therapeutics ( JSPR ) said Tuesday that Health Canada has cleared its clinical trial application for a phase 1b/2a asthma challenge study assessing briquilimab, an antibody therapy for mast cell-driven diseases. The phase 1b/2a asthma study is expected to enroll 30 patients across 10 sites in Canada and the European Union, aiming...
Primega Group Files Registration Statement for Secondary Offering
Primega Group Files Registration Statement for Secondary Offering
Sep 10, 2024
10:41 AM EDT, 09/10/2024 (MT Newswires) -- Primega Group Holdings ( PGHL ) filed a registration statement Tuesday that contains the preliminary prospectus for the sale of about 2.2 million of its common shares by certain selling shareholders. The company said the selling shareholders may offer or sell all or a portion of the shares covered by the preliminary prospectus...
RBC Capital Markets Provides Estimate Changes for Intermediate/Junior Gold and Silver Cos
RBC Capital Markets Provides Estimate Changes for Intermediate/Junior Gold and Silver Cos
Sep 10, 2024
10:41 AM EDT, 09/10/2024 (MT Newswires) -- RBC Capital Markets on Tuesday outlined its estimate changes for intermediate/junior gold and silver producers, reflecting updated commodity price assumptions. RBC raised Alamos Gold ( AGI ) 's price target to $23.00 from $20.00 and increased Eldorado Gold's ( EGO ) 's price target to $22.00 from $20.00. Gatos Silver ( GATO )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved